Javier Pinilla-Ibarz
Moffitt Cancer Center · H. Lee Moffitt Cancer Center and Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Javier Pinilla-Ibarz as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:57 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05694364 · Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor MalignanciesH. Lee Moffitt Cancer Center and Research Institute · completed · Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia · principal investigator
- Ph2NCT03610971 · Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase InhibitorsH. Lee Moffitt Cancer Center and Research Institute · active not recruiting · Chronic Phase Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Phase · principal investigator
- Ph1NCT00827138 · Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)Deciphera Pharmaceuticals, LLC · completed · Chronic Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:57 UTC. The ranking covers the 200 most relevant of 28 PubMed records, and a shared surname and initials can bring in a namesake. All 28 on PubMed
- A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.N Engl J Med · 2013903 citationsRCR 24.7
- Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.J Clin Oncol · 2021589 citationsRCR 33.6
- 492 citationsRCR 18.4
- 294 citationsRCR 8.0
- 294 citationsRCR 11.5
- 193 citationsRCR 3.3
- 183 citationsRCR 5.6
- A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia.Blood · 2004164 citationsRCR 2.7
- 124 citationsRCR 2.7
- Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial.JAMA Oncol · 202194 citationsRCR 5.8